{{Rsnum
|rsid=8127977
|Chromosome=21
|position=25454202
|Orientation=plus
|GMAF=0.4431
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 56.2 | 38.4 | 5.4
| HCB | 2.2 | 36.5 | 61.3
| JPT | 2.7 | 34.5 | 62.8
| YRI | 57.8 | 35.4 | 6.8
| ASW | 54.4 | 42.1 | 3.5
| CHB | 2.2 | 36.5 | 61.3
| CHD | 3.7 | 33.0 | 63.3
| GIH | 29.7 | 43.6 | 26.7
| LWK | 48.2 | 40.9 | 10.9
| MEX | 21.1 | 45.6 | 33.3
| MKK | 50.0 | 41.7 | 8.3
| TSI | 52.9 | 40.2 | 6.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=2E-6
  |OR=1.59
  |ORtxt=[1.282-1.966]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}